Results 161 to 170 of about 128,824 (278)
A sustainable business ecosystem: a case study demonstrating biochar's potential
Abstract The need for renewable, climate‐friendly resources has become urgent as legislators worldwide have sought to find ways to cut emissions while ensuring resource security for consumers. The use of biochar could help to achieve these goals. This study examines the current state of commercial biochar production and the maturity of the related ...
Kivijakola Juuso +4 more
wiley +1 more source
Exploring the 15-Minute City concept for the urban outskirts: a systematic literature review. [PDF]
Arias-Molinares D +12 more
europepmc +1 more source
Abstract The premise of a bioeconomy is the replacement of nonrenewable and unsustainable fossil‐derived resources and associated technologies with more sustainable alternatives. The adoption of biobased chemicals contributes toward the growth of a bioeconomy and is dependent on market and industry requirements.
Prisha Mandree +2 more
wiley +1 more source
Breeding planning in the context of business planning
Momm H
doaj +1 more source
Investigating factors affecting the success of health care startups in Iran. [PDF]
Majedi N, Yaghoubi M, Amiri-Ara M.
europepmc +1 more source
Business plan d'una empresa de càlcul d'estructures
Chamorro Calderón, Jesús
openalex +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Understanding attitudes and preferences towards advance care planning in older adults: Insights from a cross-sectional study in primary care. [PDF]
Anantapong K +2 more
europepmc +1 more source
Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley +1 more source

